MedTrace Logo

Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

NCT02748668 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 371

Last updated 2024-06-05

No results posted yet for this study

Summary

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Conditions

  • Extracorporeal Membrane Oxygenation

Interventions

OTHER

Blood specimen collection

Sponsors & Collaborators

  • Van Andel Research Institute

    collaborator OTHER

  • Spectrum Health Hospitals

    lead OTHER

Principal Investigators

  • Renzo Loyaga-Rendon, MD,PhD · Spectrum Health Hospitals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-20
Primary Completion
2023-08-23
Completion
2023-08-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02748668 on ClinicalTrials.gov